Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Sterile water

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    42 result(s) found for: Sterile water. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2005-000654-67 Sponsor Protocol Number: FM1 Start Date*: 2005-04-12
    Sponsor Name:Uppsala University/Uppsala County Council
    Full Title: Can patients with fibromyalgia be improved by subcutaneous injections of sterile water in tenderpoints? A randomised, controlled, tripple masked clinical trial
    Medical condition: Fibromyalgia
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-004343-12 Sponsor Protocol Number: ICARISTrialProtocol Start Date*: 2015-10-07
    Sponsor Name:Mater Research Institute University of Queensland
    Full Title: Impact on Caesarean Section Rates Following Injections of Sterile Water
    Medical condition: Back pain in labour and childbirth
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005897-54 Sponsor Protocol Number: S241-GB-08 Start Date*: 2006-02-01
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd
    Full Title: A Phase 1, Single-Centre, Single-blind, CPO Solution Human Patch Test in Healthy Subjects
    Medical condition: Not Applicable (Healthy Volunteer Study)
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-004496-10 Sponsor Protocol Number: NRL011-01/2004 Start Date*: 2005-04-05
    Sponsor Name:Norgine International Limited
    Full Title: A Phase 2a double blind, randomised, placebo controlled, two dose study to determine the effect of orally administered methylnaltrexone (MNTX) in preventing post-operative opiate induced constipati...
    Medical condition: Coated MNTX is being developed for the prevention of constipation in patients taking opioids for hip and knee replacement surgery for analgesia (pain relief). This drug is as yet unlicensed for use...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-004829-97 Sponsor Protocol Number: S241-GB-01 Start Date*: 2005-01-05
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel International R&D)
    Full Title: 96 HOUR HUMAN PATCH TEST FOR ASSESSMENT OF PRIMARY SKIN IRRITATION
    Medical condition: Not Applicable (Healthy Volunteer Study)
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-003232-35 Sponsor Protocol Number: 197-2004 Start Date*: 2007-08-17
    Sponsor Name:Medizin Universität Wien
    Full Title: Dantrolen as treatment for hyperthermia in patients with subarachnoidal hemorrhage
    Medical condition: Fever episodes occur in more than 50%of patients with subarachnoidal hemorrhage despite antibiotic and antipyretic therapy.The exact mechanism of hyperthermia-induced brain injury is not known. Hyp...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020846 Hyperthermia therapy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2015-003005-41 Sponsor Protocol Number: CS0866-A-U101 Start Date*: 2015-07-24
    Sponsor Name:Sankyo Pharma Development
    Full Title: A Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of a Compounded 4 mg/mL Olmesartan Medoxomil Suspension (Total Dose 40 mg) and 40 mg Olmesartan Medoxomil Tablets (Beni...
    Medical condition: Not applicable - Healthy Volunteer study
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2005-000704-14 Sponsor Protocol Number: S241-GB-07 Start Date*: Information not available in EudraCT
    Sponsor Name:Stiefel Laboratories International Division
    Full Title: Human 96 Hour Repeat Open Application Test for Assessment of Skin Irritation
    Medical condition: Not applicable (Healthy Volunteer Study)
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2017-000403-24 Sponsor Protocol Number: HepNet-SofE Start Date*: 2017-10-17
    Sponsor Name:Hannover Medical School
    Full Title: HepNet pilot trial: Multicenter trial for the treatment of chronic hepatitis E with sofosbuvir (SofE)
    Medical condition: Adults with chronic Hepatitis E virus infection, who either failed to achieve clearance of infection after ribavirin therapy or have contraindications for ribavirin.
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10019768 Hepatitis E PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2014-004555-31 Sponsor Protocol Number: ZS-005 Start Date*: 2015-04-17
    Sponsor Name:ZS Pharma Inc
    Full Title: A Phase 3 Multicenter, Multi-dose, Open-label Maintenance Study to Investigate the Long-term Safety and Efficacy of ZS (Sodium Zirconium Cyclosilicate), an Oral Sorbent, in Subjects with Hyperkalemia
    Medical condition: Hyperkalemia
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004861 10020647 Hyperkalemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) GB (Completed) NL (Completed) RO (Completed)
    Trial results: View results
    EudraCT Number: 2021-006295-17 Sponsor Protocol Number: MedTrace-002 Start Date*: 2022-04-08
    Sponsor Name:MedTrace Pharma
    Full Title: A Phase 3, Multicenter, Open Label Study to Confirm the Diagnostic Potential of Intravenously Administered 15O- H2O to Identify Coronary Artery Disease During Pharmacological Stress and Resting Con...
    Medical condition: Coronary Artery Disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004849 10006896 CAD LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2010-023543-15 Sponsor Protocol Number: CL09002 Start Date*: 2011-01-24
    Sponsor Name:BioCis Pharma Oy
    Full Title: Double-blind, placebo-controlled, multi-centre Phase II study to investigate dose response, safety, tolerability and efficacy of topical twice daily doses of 2.5% and 5% cis-urocanic acid in compar...
    Medical condition: Chronic moderate or severe atopic dermatitis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-014550-14 Sponsor Protocol Number: DPSI-Acanya-P4-02 / 290622BS Start Date*: 2009-09-25
    Sponsor Name:Dow Pharmaceutical Sciences, Inc on behalf of Coria Laboratories
    Full Title: A single center, randomized, controlled study to determine the irritant potential of topical acne formulations on intact healthy skin on the back following repeated application during a 21-day trea...
    Medical condition: Cumulative irritation test
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-008332-90 Sponsor Protocol Number: CL08004 Start Date*: 2009-02-10
    Sponsor Name:BioCis Pharma Oy
    Full Title: Double-blind, vehicle-controlled, single centre Phase I/IIa study with topical twice daily doses of 5% cis-urocanic acid to investigate pharmacokinetics, safety, tolerability, and efficacy for up t...
    Medical condition: Mild to moderate plaque psoriasis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005075-10 Sponsor Protocol Number: CL08002 Start Date*: 2008-10-01
    Sponsor Name:BioCis Pharma Oy
    Full Title: Double-blind, vehicle-controlled, two-phase, single centre Phase I/IIa study with topical twice daily doses of 5% cis-urocanic acid to investigate pharmacokinetics, safety, tolerability and efficac...
    Medical condition: Chronic mild to moderate atopic dermatitis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-000006-32 Sponsor Protocol Number: IXR-203-30-204 Start Date*: 2005-06-13
    Sponsor Name:IVAX RESEARCH, INC.
    Full Title: A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, DOSE RANGING STUDY TO DETERMINE THE EFFICACY AND SAFETY OF AN INVESTIGATIONAL INTRANASAL CORTICOSTEROID COMPARED TO PLACEBO AND OPEN-LABEL FLUTICASONE PR...
    Medical condition: Perennial (persistant) Allergic Rhinitis
    Disease:
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: SK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-004152-10 Sponsor Protocol Number: EMPATHY Start Date*: 2020-01-30
    Sponsor Name:IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
    Full Title: Evaluating the Short-Term Renal and Systemic Effects of SGLT2 Inhibition in Non-Diabetic Patients at Risk of Accelerated GFR Decline Because of Glomerular Hyperfiltration: a sequential OFF-ON-OFF S...
    Medical condition: Obesity Renal chronic disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 10027433 - Metabolism and nutrition disorders 10029883 Obesity PT
    21.1 100000004857 10009119 Chronic renal failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2018-002543-28 Sponsor Protocol Number: MIRA1 Start Date*: 2020-01-15
    Sponsor Name:MEGAINPHARM GmbH
    Full Title: A multi-center, randomized, placebo-controlled, double-blind, dose-finding clinical trial investigating the short-term relief of symptoms of acute pharyngitis such as throat soreness pain and diffi...
    Medical condition: Acute Pharyngitis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-002301-23 Sponsor Protocol Number: BAP00414 Start Date*: 2005-12-14
    Sponsor Name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Full Title: A Phase 3, Randomized, Double-Blind Study Of Ceftobiprole Medocaril Versus Vancomycin With Ceftazidime in The Treatment Of Complicated Skin And Skin Structure Infections
    Medical condition: complicated skin and skin structure infection
    Disease: Version SOC Term Classification Code Term Level
    5.1 10040786 HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) LV (Completed) LT (Completed) EE (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2013-001132-22 Sponsor Protocol Number: GEM-1202 Start Date*: 2014-02-24
    Sponsor Name:Grupo Español Multidisciplinar de Melanoma
    Full Title: A MULTICENTER, SINGLE ARM, PHASE 2 CLINICAL STUDY ON THE COMBINATION OF RADIATION THERAPY AND IPILIMUMAB, FOR THE TREATMENT OF PATIENTS WITH MELANOMA AND BRAIN METASTASES.
    Medical condition: Patients with melanoma and brain metastases
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 04 02:06:36 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA